Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Study of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of Atiprimod for Patients With Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
DTPACE Followed by Tandem Transplant With Melphalan (MEL) 200 Versus MEL/Dexamethasone/Thalidomide (DT) Platinol/Adriamycin/Etoposide (PACE) Hybrid and DTPACE Consolidation
- Status
- COMPLETED
- Phase
- PHASE3
Dexamethasone or Dexamethasone in Combination With Thalidomide as Salvage Therapy
- Status
- COMPLETED
- Phase
- PHASE2
D.T. PACE Versus High Dose Melphalan and Autologous Transplant in Patients With Previously Treated Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation Relapse
- Status
- COMPLETED
- Phase
- PHASE2
Anti-Angiogenesis Therapy Using Thalidomide in Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Study Comparing STR (Skeletal Targeted Radiotherapy) Plus Melphalan to Melphalan Alone, With Stem Cell Transplant in Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE3
UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
Study of Tumor Antigen-Pulsed Autologous Dendritic Cell Vaccination Administrated Subcutaneously or Intranodally
- Status
- COMPLETED
- Phase
- PHASE2
Study of Combination PS-341 and Thalidomide in Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide
- Status
- COMPLETED
- Phase
- PHASE2
Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide
- Status
- COMPLETED
- Phase
- PHASE2
UARK 2003-33, Total Therapy III
- Status
- COMPLETED
- Phase
- PHASE2
An Open Protocol for the Compassionate Use of Thalidomide
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Repeat-Dose Pharmacokinetics and Pharmacodynamics of Bortezomib in Patients With Relapsed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Study of SGN-40 in Patients With Refractory or Recurrent Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Xcellerated T CellsTM in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102)
- Status
- COMPLETED
- Phase
- PHASE3